Hear three of McKinsey’s life-sciences experts describe the potentially transformative effects of AI, data, and analytics on the process of drug discovery. Alex Devereson, Christoph Sandler, and Lydia The envision a world in which scientists will be able to automate previously manual tasks and generate new insights at an unprecedented pace. But, for that to happen, companies will need to radically change the way they work.
Many diseases today don’t have a cure. One reason is that drug discovery is difficult: finding and developing an effective medicine is a yearslong and very expensive process. But maybe it doesn’t have to be. Experts say AI—if properly integrated into scientists’ research—could revolutionize drug discovery, making it possible for more patients to get the treatments they need.
The view to 2030
‘We will have life-changing, game-changing drugs ... getting to the right patient at the right time’
More on the future of biotech
Article
AI in biopharma research: A time to focus and scale
-
By focusing on specific scientific and operational pain points and fully integrating AI into research workflows, biopharma companies...
Article
Self-learning: The dawn of a new biomedical R&D paradigm
-
Science and technology are driving breakthroughs at each stage of the biomedical R&D value chain. Enhancing feedback loops...
Article
What are the biotech investment themes that will shape the industry?
-
From 2019 to 2021, venture capitalists plowed $35 billion into biotech companies with advanced platform technologies that could...
Article
Transforming biopharma R&D at scale
-
Transformations often struggle to scale up and make change stick. To achieve lasting impact, high-performing R&D organizations...
Article
Better data for better therapies: The case for building health data platforms
-
Health data platforms that participants trust could bring an end to today’s reductionist approach to drug development,...
Article
Generating real-world evidence at scale using advanced analytics
-
As pharma companies apply advanced analytics to generate new types of evidence, how do they decide which use cases to target...
Article
Ten battlegrounds for digital and analytics in life sciences
-
Life-sciences companies have yet to realize the full potential of digital and analytics. Pioneers are finding success by focusing...
Article
Creating value from next-generation real-world evidence
-
Leading pharma companies are applying advanced analytics to real-world evidence generation to deliver impact at scale. How can...